A comparison of CNN architectures for Alzheimer's disease detection in single-view MRI scans

• URL: http://arxiv.org/abs/2608.11762v1
• Date: Wed, 12 Aug 2026 08:01:15 GMT
• Title: A comparison of CNN architectures for Alzheimer's disease detection in single-view MRI scans
• Abstract summary: Alzheimer's disease is a leading cause of death with no cure.<n>This work proposes a benchmark that evaluates ten different convolutional neural network (CNN) architectures.<n>A two-stage transfer learning and full fine-tuning pipeline is introduced to perform training using a class-balanced subset.<n>The best results were achieved by VGG16, with a 0.9637 validation accuracy and a 0.9533 test accuracy score.
• Score: 0.7646713951724009
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Alzheimer's disease is a leading cause of death with no cure. Therefore, early detection is critical to slow progression and preserve quality of life. Diagnosis relies on medical history, cognitive tests, physical exams, and MRI brain scans, making deep learning suitable for Alzheimer's classification. This work proposes a benchmark that evaluates ten different convolutional neural network (CNN) architectures (including ResNet, DenseNet, MobileNet, EfficientNet, and VGG family models) under the same held-out test split protocol. A two-stage transfer learning and full fine-tuning pipeline is introduced to perform training using a class-balanced subset (3,900 images) derived from the OASIS medical imaging dataset, comprising 86,437 single-view MRI brain scans labeled into four classifications of Alzheimer's disease: Non-Demented, Very Mild Dementia, Mild Dementia, and Moderate Dementia. The best results were achieved by VGG16, with a 0.9637 validation accuracy and a 0.9533 test accuracy score. A key finding documented in this work is the difficulty of classifying the transition from Non-Demented to Very Mild Demented stages, observed consistently across all ten architectures.

Related papers

• NeuroSymAD: A Neuro-Symbolic Framework for Interpretable Alzheimer's Disease Diagnosis [35.4733004746959]
  NeuroSymAD is a neuro-symbolic framework that synergizes neural networks with symbolic reasoning.<n>A neural network percepts brain MRI scans, while a large language model distills medical rules to guide a symbolic system in reasoning over biomarkers and medical history.
  arXiv  Detail & Related papers  (2025-03-01T14:29:39Z)
• Brain Tumor Classification on MRI in Light of Molecular Markers [56.99710477905796]
  Co-deletion of the 1p/19q gene is associated with clinical outcomes in low-grade gliomas.<n>This study aims to utilize a specially MRI-based convolutional neural network for brain cancer detection.
  arXiv  Detail & Related papers  (2024-09-29T07:04:26Z)
• AXIAL: Attention-based eXplainability for Interpretable Alzheimer's Localized Diagnosis using 2D CNNs on 3D MRI brain scans [43.06293430764841]
  This study presents an innovative method for Alzheimer's disease diagnosis using 3D MRI designed to enhance the explainability of model decisions. Our approach adopts a soft attention mechanism, enabling 2D CNNs to extract volumetric representations. With voxel-level precision, our method identified which specific areas are being paid attention to, identifying these predominant brain regions.
  arXiv  Detail & Related papers  (2024-07-02T16:44:00Z)
• Alzheimer's Magnetic Resonance Imaging Classification Using Deep and Meta-Learning Models [2.4561590439700076]
  This study focuses on classifying Magnetic Resonance Imaging (MRI) data for Alzheimer's disease (AD) by leveraging deep learning techniques characterized by state-of-the-art CNNs. Alzheimer's disease is the leading cause of dementia in the elderly, and it is an irreversible brain illness that causes gradual cognitive function disorder. In future, this study can be extended to incorporate other types of medical data, including signals, images, and other data.
  arXiv  Detail & Related papers  (2024-05-20T15:44:07Z)
• Introducing an ensemble method for the early detection of Alzheimer's disease through the analysis of PET scan images [0.8192907805418583]
  This study delves into the challenging task of classifying Alzheimer's disease into four distinct groups: control normal (CN), progressive mild cognitive impairment (pMCI), stable mild cognitive impairment (sMCI), and Alzheimer's disease (AD) Several deep-learning and traditional machine-learning models have been used to detect Alzheimer's disease. The results show that using deep-learning models to tell the difference between MCI patients gives an overall average accuracy of 93.13% and an AUC of 94.4%.
  arXiv  Detail & Related papers  (2024-03-17T16:12:50Z)
• Hybridized Convolutional Neural Networks and Long Short-Term Memory for Improved Alzheimer's Disease Diagnosis from MRI Scans [2.621434923709917]
  This study aims to present a hybrid model that combines a CNN model's feature extraction capabilities with an LSTM model's detection capabilities. The training of the hybrid model involved utilizing the ADNI dataset. The model achieved a level of accuracy of 98.8%, a sensitivity rate of 100%, and a specificity rate of 76%.
  arXiv  Detail & Related papers  (2024-03-08T14:34:32Z)
• Behavior Score-Embedded Brain Encoder Network for Improved Classification of Alzheimer Disease Using Resting State fMRI [36.40726715739385]
  We propose a behavior score-embedded encoder network (BSEN) that integrates regularly adminstrated psychological tests information into the encoding procedure of representing subject's restingstate fMRI data. BSEN is based on a 3D convolutional autoencoder structure with contrastive loss jointly optimized using behavior scores from MiniMental State Examination (MMSE) and Clinical Dementia Rating (CDR) Our proposed classification framework of using BSEN achieved an overall recognition accuracy of 59.44% (3-class classification: AD, MCI and Healthy Control) and we further extracted the most discriminative regions between healthy control (HC) and
  arXiv  Detail & Related papers  (2022-11-04T09:58:45Z)
• Brain Age Estimation From MRI Using Cascade Networks with Ranking Loss [75.03117866578913]
  A novel 3D convolutional network, called two-stage-age-network (TSAN), is proposed to estimate brain age from T1-weighted MRI data. Experiments with $6586$ MRIs showed that TSAN could provide accurate brain age estimation.
  arXiv  Detail & Related papers  (2021-06-06T07:11:25Z)
• Deep Convolutional Neural Network based Classification of Alzheimer's Disease using MRI data [8.609787905151563]
  Alzheimer's disease (AD) is a progressive and incurable neurodegenerative disease which destroys brain cells and causes loss to patient's memory. In this paper, we have proposed a smart and accurate way of diagnosing AD based on a two-dimensional deep convolutional neural network (2D-DCNN) using imbalanced three-dimensional MRI dataset. The model classifies MRI into three categories: AD, mild cognitive impairment, and normal control: and has achieved 99.89% classification accuracy with imbalanced classes.
  arXiv  Detail & Related papers  (2021-01-08T06:51:08Z)
• Multimodal Inductive Transfer Learning for Detection of Alzheimer's Dementia and its Severity [39.57255380551913]
  We present a novel architecture that leverages acoustic, cognitive, and linguistic features to form a multimodal ensemble system. It uses specialized artificial neural networks with temporal characteristics to detect Alzheimer's dementia (AD) and its severity. Our system achieves state-of-the-art test accuracy, precision, recall, and F1-score of 83.3% each for AD classification, and state-of-the-art test root mean squared error (RMSE) of 4.60 for MMSE score regression.
  arXiv  Detail & Related papers  (2020-08-30T21:47:26Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.